Active - Last updated on: March 25, 2025
GSK Plc is a UK-listed multinational pharmaceutical company based around two divisions: Prescription medicines (Includes ViiV HIV joint venture with Pfizer and Shionogi) and Vaccines. In prescription drugs and Vaccines its key franchises include HIV & Shingrix (shingles vaccine).
The GSK plc ADRhedged™ (the “Series”) seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of GSK plc in its local market.
| Fund Inception | 01/03/2025 |
| Expense Ratio | 0.19% |
| CUSIP | 74016W874 |
| Total Assets | $1,659,812.74 |
| Symbol | GSKH |
| Lead Market Maker | GTS Securities |
| NAV Symbol | GSKH.NAV |
| Shares Out. Symbol | GSKH.SO |
| NAV | $55.33 |
| Change | $-0.14 |
| Change % | -0.25% |
| Premium/Discount to NAV | 0.14% |
| Closing Market Price | $55.41 |
| Change | $-0.02 |
| Change % | -0.04% |
| 30 Day Median Bid/Ask Spread | 0.24% |
| Total Return | Since Inception |
|---|---|
| At NAV | $— |
| At Market Price | $— |
Returns are average annualized total returns, except those for periods of less than one year, which are cumulative.
The performance data quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. Market price returns are based upon the closing composite market price and do not represent the returns you would receive if you traded shares at other times.
| Ticker | Name | Shares | Market Value | % of Net Assets |
|---|---|---|---|---|
| GSK | GSK plc | 42,861.00 | $1,653,577.38 | 100.36% |
| — | Cash | — | $-5,976.49 | -0.36% |
Fund holdings and allocations are subject to change at any time.
Notifications
